These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6373005)

  • 61. [New approach to the development of Ca antagonists].
    Baba A; Arita M; Masuyama Y
    Nihon Rinsho; 1989 Aug; 47(8):1788-93. PubMed ID: 2585742
    [No Abstract]   [Full Text] [Related]  

  • 62. Some similarities and differences between verapamil and the dihydropyridines.
    Antonios TF; MacGregor GA
    J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Verapamil: a calcium-channel blocker.
    Bourget C
    Dimens Crit Care Nurs; 1982; 1(3):134-8. PubMed ID: 6282551
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revisiting calcium channel blockers--from basic facts to clinical practice.
    S Afr Med J; 1996 Jun; 86 Suppl 3():C171-3. PubMed ID: 8768782
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of angina pectoris with calcium antagonists].
    Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M
    Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971
    [No Abstract]   [Full Text] [Related]  

  • 67. Calcium channel blockers revisited.
    Cheung BM; Kumana CR
    Hong Kong Med J; 2002 Aug; 8(4):300-1. PubMed ID: 12167737
    [No Abstract]   [Full Text] [Related]  

  • 68. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of cardiomyopathy using Ca blockers].
    Matsumori A; Tominaga M; Kawai C
    Nihon Rinsho; 1989 Aug; 47(8):1825-30. PubMed ID: 2585747
    [No Abstract]   [Full Text] [Related]  

  • 70. Calcium channel blockers in primary pulmonary hypertension.
    Rubin LJ
    Chest; 1985 Oct; 88(4 Suppl):257S-260S. PubMed ID: 4042732
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Calcium channel blockers and their value in the treatment of bronchial asthma].
    Wasek Z
    Pneumonol Pol; 1988 Oct; 56(10):467-71. PubMed ID: 3254510
    [No Abstract]   [Full Text] [Related]  

  • 72. Diagnosis and treatment of Prinzmetal's variant angina.
    McMahon MT; McPherson MA; Talbert RL; Greenberg B; Sheaffer SL
    Clin Pharm; 1982; 1(1):34-42. PubMed ID: 6764160
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Therapy of dyskinesia of Oddiś sphincter with calcium antagonists].
    Simon L; Kovács S
    Orv Hetil; 1983 Nov; 124(46):2805-9. PubMed ID: 6646746
    [No Abstract]   [Full Text] [Related]  

  • 74. Mechanism(s) of calcium antagonists and ischemia.
    Hugenholtz PG; de Jong JW
    Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
    Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
    Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Calcium-channel blocking agents for gastrointestinal disorders.
    Castell DO
    Am J Cardiol; 1985 Jan; 55(3):210B-213B. PubMed ID: 3881916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Calcium channel blockers in the management of arterial hypertension.
    Thomas T; Vidt DG
    Cleve Clin J Med; 1987; 54(6):529-36. PubMed ID: 3319284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.